Markets:

Overview

News

Currencies

International

Treasuries

Jazz Pharmaceuticals plc - Ordinary Shares (NQ:JAZZ)

167.85 +1.50 (+0.90%)

Streaming Delayed Price Updated: 4:00 PM EST, Jan 27, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Jazz Pharmaceuticals plc - Ordinary Shares

< Previous 1 2

...

10 11 12 13 14 15 16 17 Next >

10 Biggest Price Target Changes For Friday ↗

December 17, 2021

Piper Sandler boosted Accenture plc (NYSE:ACN) pric...

Via Benzinga

7 Meme Stocks to Buy on Their Market Slump and Rebound ↗

December 14, 2021

These seven meme stocks suffered downturns recently, but they have the appropriate catalysts to move upward in the near term.

Via InvestorPlace

Are Cannabinoids the Next Frontier of Pharmaceuticals? This Company Thinks So and Wants to Lead the Pack ↗

December 14, 2021

Photo by Michael Longmire on...

Via Benzinga

How Pfizer Is Getting Into Cannabis With $6.7B Arena Pharma Deal ↗

December 13, 2021

The two publicly-traded companies confirmed Monday that they have signed a definitive agreement under which Pfizer will acquire all outstanding shares of Arena for $100 per share in an all-cash...

Via Talk Markets

Topics Cannabis

How Pfizer Is Getting Into Cannabis With $6.7B Arena Pharma Deal ↗

December 13, 2021

Pharmaceutical giant Pfizer Inc. (NYSE:PFE) is e...

Via Benzinga

Topics Cannabis

Jazz Posts New Data for ALL/LBL Treatment At ASH 2021 Annual Meeting ↗

December 13, 2021

Jazz Pharmaceuticals plc (NASDAQ: JAZZ) revealed initial positive results from a Phase 2/3 trial of intramuscular (IM) administration of Rylaze (asparaginase...

Via Benzinga

Jupiter Wellness Just Reported A Big Move In Pharma ↗

December 10, 2021

Image provided by Jupiter Wellness of their new lab. The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content...

Via Benzinga

3 High-Growth Stocks That Are Screaming Buys in December ↗

December 09, 2021

Now is a good time to be greedy and buy up these depressed stocks.

Via The Motley Fool

Got $5,000? Buy These 3 Hot Pot Stocks Immediately ↗

November 27, 2021

There might not be a better time to buy these three cannabis stocks than right now.

Via The Motley Fool

Topics Cannabis

EXCLUSIVE: Cannabis-Based Drug Approved For Cancer Treatment In Peru ↗

November 22, 2021

Cannabis-based drug Sativyl has been approved as a treatment for cancer-related pain in Peru.

Via Benzinga

2 Top Marijuana Stocks to Buy for the Long Haul ↗

November 21, 2021

If you're patient with these investments, they can produce great returns for your portfolio.

Via The Motley Fool

Topics Cannabis

Better Buy: Compass Pathways vs. Jazz Pharmaceuticals ↗

November 21, 2021

Both of these biotech stocks are innovators, but one is more likely to hit it out of the park.

Via The Motley Fool

The Week In Cannabis: Earnings Season, A GOP Legalization Bill, Seth Rogen & Sarah Silverman's Campaign ↗

November 12, 2021

Below is a recap of the main news related to the cannabis industry and markets for the week of November 8, 2021.

Via Benzinga

Topics Cannabis

7 F-Rated Stocks to Sell Before We Reach Christmas ↗

November 10, 2021

It's just as important to know what stocks to sell as it is to know what stocks to buy. These stocks are prime examples of stocks to drop now.

Via InvestorPlace

Jazz Pharmaceuticals PLC (JAZZ) Q3 2021 Earnings Call Transcript ↗

November 10, 2021

JAZZ earnings call for the period ending September 30, 2021.

Via The Motley Fool

Topics Earnings

Jazz Pharmaceuticals Reports Q3 Financial Results, Raises Full-Year Earnings Guidance ↗

November 09, 2021

Jazz Pharmaceuticals plc (NASDAQ:JAZZ), a global biopharma...

Via Benzinga

Jazz Pharmaceuticals: Q3 Earnings Insights ↗

November 09, 2021

Jazz Pharmaceuticals (NASDAQ: JAZZ) reported its Q3 earnings results on Tuesday, November 9, 2021 at 04:00 PM. Here's what investors need to know about the announcement....

Via Benzinga

The Daily Biotech Pulse: Pfizer Reports Solid Q3 Earnings, Regulatory Setback For Legend, Lilly to Supply Additional COVID-19 Antibody Cocktails To US ↗

November 02, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus SAB Spikes On Analyst Action SAB Biotherapeutics, Inc. (NASDAQ: SABS) shares...

Via Benzinga

The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data ↗

November 09, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck Gets Antitrust Nod For Acceleron Deal In Germany, Austria, Announces...

Via Benzinga

Lexaria Announces DehydraTECH-CBD Versus Prescription CBD Program In Treating Seizures ↗

November 01, 2021

Lexaria Bioscience Corp (NASDAQ: LEXX) has commenced a new study to compare the effectiveness of Epidiolex to DehydraTECH-cannabidiol (CBD) for reducing seizure...

Via Benzinga

The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More ↗

November 08, 2021

Biotech stocks reversed course and closed the week ended Nov. 5 lower, squandering the gains notched early in the week. What was good news for Pfizer, Inc. (NYSE: PFE) turned out...

Via Benzinga

2 Top Growth Stocks to Buy Heading Into November ↗

October 30, 2021

There's plenty of growth on the horizon for these stocks, which are trading near their lows for the year.

Via The Motley Fool

Jim Cramer Considers nCino As Winner, Prefers This Stock Over Perficient ↗

October 27, 2021

On CNBC’s "Mad Money ...

Via Benzinga

Leading the Charge to Develop the First Orexin-Targeted Therapy to Address Narcolepsy at its Root Cause ↗

October 20, 2021

Photo by MART PRODUCTION from Pexels The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial...

Via Benzinga

SEC Charges Former Goldman Sachs Officer For Insider Trading On 2 M&A Deals ↗

October 01, 2021

The Securities and Exchange Commission has charged a former Goldman Sachs (NYSE: GS) compliance analyst with using confidential information to generate over $...

Via Benzinga

Topics Regulatory Compliance

Needham Initiates Coverage With Buy For This Narcolepsy Player ↗

September 23, 2021

Needham

Via Benzinga

The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal ↗

October 06, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 5) Bicycle Therapeutics plc (...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For October 5, 2021 ↗

October 05, 2021

Upgrades Wolfe Research upgraded the previous rating for PACCAR Inc (NASDAQ:

Via Benzinga

The Daily Biotech Pulse: J&J Files For Booster Dose Authorization, Gemini Restructures, Strata Skin CFO Departs, Kaleido Reports Positive Readout ↗

October 05, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 4) Avadel Pharmaceuticals plc (...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 23, 2021 ↗

September 23, 2021

Upgrades Barclays upgraded the previous rating for Warner Music Group Corp (NASDAQ:

Via Benzinga

< Previous 1 2

...

10 11 12 13 14 15 16 17 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Jazz Pharmaceuticals plc - Ordinary Shares (NQ:JAZZ)

All News about Jazz Pharmaceuticals plc - Ordinary Shares

Starting at $3.75/week.

Subscribe Today